1. Home
  2. LMRI vs QURE Comparison

LMRI vs QURE Comparison

Compare LMRI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LMRI

Lumexa Imaging Holdings Inc. Common Stock

N/A

Current Price

$14.44

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.09

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMRI
QURE
Founded
2018
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2025
2007

Fundamental Metrics

Financial Performance
Metric
LMRI
QURE
Price
$14.44
$25.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$22.67
$58.55
AVG Volume (30 Days)
621.0K
1.7M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,003,375,000.00
$15,751,000.00
Revenue This Year
$9.29
N/A
Revenue Next Year
$5.01
$142.93
P/E Ratio
N/A
N/A
Revenue Growth
1.38
N/A
52 Week Low
$14.00
$7.76
52 Week High
$19.45
$71.50

Technical Indicators

Market Signals
Indicator
LMRI
QURE
Relative Strength Index (RSI) N/A 54.62
Support Level N/A $21.64
Resistance Level N/A $23.34
Average True Range (ATR) 0.00 1.72
MACD 0.00 0.36
Stochastic Oscillator 0.00 51.64

Price Performance

Historical Comparison
LMRI
QURE

About LMRI Lumexa Imaging Holdings Inc. Common Stock

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: